Salivary Drug Concentration Exploratory Study of Cetylpyridinium Chloride Buccal Tablets

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 10, 2023

Primary Completion Date

April 18, 2023

Study Completion Date

April 18, 2023

Conditions

Pharyngitis AcuteGingivitis

Interventions

DRUG

Cetylpyridinium Chloride Buccal Tablets

Subjects administrated single dose of Cetylpyridinium Chloride Buccal Tablet

Trial Locations (1)

Peking University People's Hospital, Beijing

All Listed Sponsors

lead

Peking University People's Hospital

OTHER